Gordon Dean Ginder, MD

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

Virginia Commonwealth University School Of Medicine (Previously MCV) - Richmond VA
Rank: Full Professor
Years: 1997-Present

None Reported

Acute Myeloid Leukemia-How the Uninsured Fare
Cancer
Volume: 10
Date: 03 2011

Solution structure and dynamic analysis of MBD2 methylbinding domain bound to methylated DNA sequence
Nucleic Acids Research
39(15):6741-52
Date: 04 2011

p66Alpha-Mbd2 coiled-coil interaction and recruitment of Mi-2 are critical for globin gene silencing by the MBD2-NuRD complex
Proceedings of the National Academy of Sciences USA
108(18):7487-92
Date: 05 2011

Methyl binding domain 2 dependent proliferation and survival of breast cancer cells
Molecular Cancer Research
9(8):1152-1162
Date: 08 2011

Hematologic malignancies: an opportunity to fill a gap in cancer surveillance
Cancer Causes Control
Volume: 23(8)
Date: 08 2012

Barriers to clinical trial enrollment:differences between African American and white cancer patients identified at the time of eligibility assessment
Clinical Trials
Volume: 9(6)
Date: 12 2012

Mi-2 beta mediated silencing of the fetal gamma globin gene in adult erythroid cells
Blood
Volume: 121(17)
Date: 04 2013

Probing the dynamic distribution of bound states for methylcytosine binding domains on DNA
Journal of Biological Chemistry
Volume: 289(3)
Date: 01 2014

Depletion of the chromatin remodeler CHD4 sensitizes AML blasts to genotoxic agents and reduces tumor formation.
Blood
126(12)1462-72
Date: 09 2015

Readers of DNA Methylation, The MBD2 NuRD Family as Potential Therapeutic Targets
Pharmacol. Ther.
184;98-111
Date: 04 2018